Overview of: Devereux G, Cotton S, Nath M, et al Bisoprolol in patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS randomized clinical trial. JAMA 2024;332:462-70.
Overview of: Devereux G, Cotton S, Nath M, et al Bisoprolol in patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS randomized clinical trial. JAMA 2024;332:462-70.
Commentary on: Lafayette R, Kristensen J, Stone A, et al Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet 2023;402:859-70.Series co-ordinator: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George's, University of London, UK.

